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ABSTRACT
Objective: Symptoms of anxiety and depression often
co-exist with cardiovascular disease (CVD), yet little is
known about the association with left ventricular (LV)
subclinical dysfunction. We aimed to study the cross-
sectional associations of previous, current and
repeated depression or anxiety symptoms, with
sensitive indices of LV systolic and diastolic function,
based on tissue Doppler (TD) and speckle tracking
(ST) imaging methods.
Methods: A random selection of 1296 individuals free
from known CVD, hypertension and diabetes were
examined with echocardiography at baseline of the
third Nord-Trøndelag Health Study, (HUNT3, 2006–
2008). The primary outcomes were LV diastolic
function (e0) and LV systolic function (longitudinal
global strain). The primary exposures were self-report
on the Hospital Anxiety and Depression Scale (HADS).
Associations between outcomes and baseline
exposures were available for 1034 (80%), and with
previous and repeated exposures for 700 participants
who also participated in HUNT2 (1995–1997).
Results: Previous and repeated depression symptoms,
but not current depression, were linearly associated
with a reduction in e0. The average sum of two
repeated HADS-D scores 10 years apart had the
strongest effect on e0 (−8.3%; 95% CI −13.9% to
−2.7%) per 5 units. We observed a sex difference
between depression symptoms and longitudinal global
strain (p for interaction 0.019), where women had a
marginal negative effect. Anxiety symptoms, neither
previous, current nor repeated were associated with
subclinical LV dysfunction.
Conclusions: In a healthy sample, confirmed free of
CVD, past and repeated depression symptoms were
associated with subclinical LV dysfunction. Thus,
depression symptoms might represent a modifiable
risk factor for future CVD.
INTRODUCTION
Subclinical cardiac dysfunction assessed by
tissue Doppler imaging (TDI) is shown to be
an independent predictor of future cardio-
vascular disease (CVD) morbidity and mor-
tality in a general population with normal
conventional echocardiographic examina-
tions.1 Even though depression and anxiety
symptoms are associated with increased risk
for future incidence of CVD,2–7 it is not clear
if these are markers for subclinical cardiac
dysfunction. There are many plausible
pathogenic mechanisms for anxiety and
KEY QUESTIONS
What is already known about this subject?
▸ Subclinical cardiac dysfunction assessed by
tissue Doppler imaging (TDI) is shown to be an
independent predictor for future cardiovascular
disease (CVD). Even though depression or
anxiety symptoms may represent modifiable risk
factors for future incident CVD, it is not clear if
these are markers for subclinical cardiac dys-
function. Only one previous study has examined
the association between TDI measures and
depression symptoms. That study included sub-
jects with hypertension, metabolic disease and
diabetes, all which are potential confounders in
the observed association between depression
and subclinical cardiac dysfunction.
What does this study add?
▸ The study adds knowledge about the association
between depression and anxiety symptoms with
TDI measures in a population confirmed free of
CVD. Previous and repeated depression symp-
toms, but not current depression symptoms,
were associated with subclinical diastolic dys-
function measured by e0 in both sexes, and mar-
ginally with subclinical systolic function
measured by longitudinal global strain in
women. Neither current nor recurrent anxiety
symptoms were associated with subclinical left
ventricular cardiac function.
How might this impact clinical practice?
▸ Previous and repeated depression symptoms
might represent a modifiable risk factor for
future CVD. Women might be more prone than
men to develop systolic dysfunction due to pro-
longed depression symptoms.
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depression symptoms to represent early modifiable risk
factors for CVD, including neurohormonal stress,
inflammation and behaviour.8–10
To the best of our knowledge, no study has examined
the association of anxiety symptoms and subclinical
cardiac dysfunction measured by echocardiography or
MRI, and only one study has examined depression
symptoms in this context.11 Kim et al11 previously found
that early left ventricular (LV) diastolic function was
reduced in participants with mild or moderate depres-
sion symptoms compared to in participants with no
depression symptoms. However, they11 included people
with hypertension, diabetes and metabolic syndrome, all
which may cause both the presence of subclinical
cardiac dysfunction12–14 and depression symptoms.15
Depression is known to have a recurrent nature.15
Limited evidence suggests that repeated episodes of
depression or anxiety symptoms might be more strongly
associated with CVD than single depressive
episodes.4 7 16 17
Therefore, our aim was to investigate the associations
of previous, current and repeated reports of anxiety
or depression with sensitive indices of LV systolic and
diastolic function in a random sample of healthy
adults.
METHODS
Study population and setting
All 93 210 citizens aged ≥20 years in Nord-Trøndelag
County, Norway, received a postal invitation to partici-
pate in the third wave of HUNT (HUNT3, 2006–2008,
http://www.ntnu.edu/hunt). In total, 50 807 (54.1%)
people participated.18 Within the HUNT3 study, 1296
participants were randomly selected for the echocardiog-
raphy study. The sample size was based on suitability in
order to obtain normal reference values of the different
LV indices by age groups, and to study the associations
of cardiac indices with traditional cardiac risk
factors.19 20 Participants were randomised for examin-
ation with echocardiography when they attended the
baseline clinical examination at the study centres.12 19–21
To be eligible, participants had to be free from known
CVD, diabetes and hypertension.12 19–21 The partici-
pants’ medical history was validated by an experienced
physician echocardiographer (HD). Furthermore, 30
participants were excluded due to significant pathology
that could influence the LV function indices. Thus, the
total number of healthy individuals with normal echo-
cardiographic findings was 1266.19
The study was approved by the Regional Committee
for Medical and Health Research Ethics, and the HUNT
Publication Board.
Current and repeated symptoms of anxiety or depression
At the HUNT3 examination, the participants received
additional health-related questionnaires, which included
reporting of anxiety and depression symptoms. These
questionnaires were taken home by participants, filled in
and returned by post in a prepaid envelope.18 The parti-
cipants were instructed to report how they felt during
the past week, using the Hospital Anxiety and
Depression Scale (HADS).22 Seven questions mirrored
depressed mood (HADS-D), and seven questions mir-
rored anxiety symptoms such as worry and restlessness
(HADS-A).23 Each subscale has a four-point Likert scale,
ranging from 0 (no symptom) to 3 (highest symptom
level), which add up to a score range from 0 to 21
points. Valid HADS-D and HADS-A scores were defined
as 5 or more questions answered on each subscale.
Missing responses among those who filled in 6 or 5
items were replaced based on the sum of completed
items multiplied by 7/6 or 7/5, respectively. In total,
1034 (82%) individuals (544 women) from the echocar-
diographic study had valid current HADS symptom
scores in HUNT3 and constitute the study population in
this study (see figure 1).
Previous HADS-A and HADS-D symptoms were avail-
able for 700 (68%) individuals (357 women) from their
participation in HUNT2 (1995–1997). To reflect the
combined burden of two repeated measurements, we
averaged the sum from each HADS subscale in HUNT2
and HUNT3.
Figure 1 Flow chart of study recruitment.
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Covariates
Demographic and lifestyle factors
Demographic and lifestyle factors were assessed from
the baseline examination in HUNT3. Marital status was
categorised into never married, married or living with
partner, and separated/divorced/widowed.
Education was categorised as elementary school
(≤9 years), high school (10–12 years) and university
(>12 years). Smoking was categorised into current, previ-
ous or never smoking. A validated index for leisure-time
physical activity was calculated as a product of exercise
frequency, exercise intensity and training session
duration.24
Clinical examination
A clinical baseline examination was performed by
trained nurses according to a standardised protocol.18
Systolic and diastolic blood pressures were measured
three times, after the participant had been seated for at
least 2 min with the cuff on, with cuff size adjusted for
arm circumference. All blood pressure measurements
were performed with the Dinamap 845XT (Criticon)
based on oscillometry. The average of the second and
third measurement was used in the analyses. Height was
measured without shoes to the nearest 1 cm and weight
with light clothing to the nearest 0.5 kg. Body mass
index (BMI) was computed as weight (in kg) divided by
the squared value of height (in metres).18
Echocardiographic acquisition, analyses and reproducibility
The participants waited about 1 h without smoking or
eating at the study site before the echocardiography.
The mean time since the last meal was 2.8 h (SD 2.1).19
All examinations were conducted by an experienced
physician echocardiographer (HD) and the participants
were examined in the left lateral decubitus position with
a high-end scanner (Vivid 7, version BT06; GE Vingmed
Ultrasound AS, Horten, Norway), using a phased-array
transducer (M3S and M4S). All the presented echocar-
diographic measurements were available in ≥96% of the
participants.19 All echocardiographic data were stored
digitally and subsequently analysed.
LV function was assessed by several well-established
echocardiographic indices of systolic and diastolic longi-
tudinal function. LV end-systolic global strain (longitu-
dinal global strain) refers to percentage of longitudinal
shortening of the myocardium of the LV during systole,
and LV peak global strain rate (longitudinal global strain
rate) refers to the respective maximal speed of longitu-
dinal global strain. Both indices were assessed by track-
ing of seven regions of interest in each of the three
apical standard views of the LV by customised software
(GcMat; GE Vingmed Ultrasound, Norway). The
method used combined tissue Doppler (TD) for track-
ing along the ultrasound beam, and tracking of grey-
scale speckles (speckle tracking (ST)) for tracking of the
regions of interest perpendicular to the ultrasound
beam.19 Longitudinal global strain and global strain rate
are both presented as the average of segmental values
when assessed in a 16 segment model of the LV.25
Further, peak mitral annular systolic velocity (s0) and
peak mitral annular early diastolic velocities (e0) were
measured in the base of the LV wall by pulsed wave TD.
The average of the inferoseptal, lateral, anterior
and inferior locations was used in the analyses.12
Correspondingly, mitral annular plane systolic excursion
(MAPSE) was measured as the average of the total systolic
cumulative excursion of the same locations.20 Left atrial
volume index (for 200 participants) and LV mass were
measured in unidimensional M-mode in the parasternal
long axis view. The LV mass was calculated by the Cube
formula: LV mass=0.8×1.04×[(intraventricular septum+LV
internal diameter+inferolateral wall thickness)3−(LV
internal diameter)3]+0.6 g.25 Ejection fraction (EF) was
analysed by calculation of end-diastolic and end-systolic
LV volumes from tracings in the four-chamber and two-
chamber view.
The reproducibility of the echocardiographic mea-
sures was excellent, with 4–8% interobserver mean
errors and 2–5% intraobserver mean errors.20 21
Statistical analysis
Clinical echocardiographic data followed a normal dis-
tribution and are presented as mean (SD). Based on
previous knowledge, longitudinal global strain was
expected to be the most sensitive index to detect sys-
tolic dysfunction and e0 the most sensitive for detecting
LV diastolic dysfunction.12 Thus, an a priori decision
was made to include these as the main analyses and
include the other LV indices as secondary analyses. The
HADS-scores were operationalised as continuous vari-
ables in all analyses. Univariate Spearman correlations
were performed between all HADS-measures and LV
function measures. Linear regression analyses were per-
formed to estimate the multivariate associations of
depression and anxiety symptoms with the different LV
function indices. All LV function indices were mutually
correlated (r 0.21–0.61, all p<0.001). The LV function
measures were log transformed in order to present all
regression coefficients as the percentage difference in
the different LV indices per specified 5 unit (95% CIs)
difference in the HADS-scores. All models were
adjusted for sex, age and average heart rate during
echocardiography as potentially confounding factors. In
model 2, we also adjusted for potential socioeconomic
confounders (ie, education and marital status). In
model 3, established cardiovascular risk factors such as
blood pressure, BMI, smoking and physical activity
index were included. We investigated the potential
effect modification by sex and age (dichotomised at
50 years of age). There were signs of effect modification
between sex and longitudinal global strain (p=0.019),
and thus we carried out separate analyses in women
and men.
All statistical analyses were performed in Stata IC/12.1
for Windows (Stata Corp LP).
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RESULTS
Table 1 displays the characteristics of the study partici-
pants at baseline. Using the cut-off recommended to
ensure depression and anxiety specificity, that is, a score
≥11 on the HADS-D and HADS-A, respectively, only 17
(1.6%) had depression and 30 (2.9%) had anxiety symp-
toms. It has earlier been found3 4 that the total HUNT
population has approximately twice this level of anxiety
and depression symptoms.
Table 2 shows that current HADS-D score was asso-
ciated with lower e0 than current HADS-A score (−2.5%
vs −1.6% per 5 units higher HADS), yet the statistical
evidence for such an association was weak for both
scales. For previous HADS-D scores, e0 was 4.8% lower
per 5 units and for the averaged sum of two repeated
HADS-D scores, e0 was approximately 10% lower per
5 units in multivariable models. In contrast, the average
of two repeated anxiety reports did not show any associ-
ation with e0. The results from analyses after adjusting
for potential socioeconomic confounders (model 2)
were similar to those in model 1. Multivariable adjust-
ment including traditional CVD risk factors such as
systolic blood pressure, BMI, smoking, physical activity
index and heart rate during echocardiography (model
3), attenuated the associations Figure 2.
Table 3 shows that the average sums of two depression
reports, but not of two anxiety reports, have a marginal
negative influence (−4%, 95% CI −8.3% to −0.3%) on
longitudinal global strain in women but not in men.
The point estimate with multivariable adjustments was
unchanged, but the statistical evidence was weaker.
There were no associations between any of the
HADS-measures and secondary measures of cardiac
function (s0, longitudinal global strain rate, MAPSE and
LV mass) in crude or fully adjusted models (data not
shown).
DISCUSSION
In the present study of a healthy adult population-based
sample, we found that previous and repeated depression
scores were associated with lower diastolic LV function
measured by e0 in both sexes. It also shows a marginally
lowered systolic dysfunction measured by longitudinal
Table 1 Characteristics of the study population at baseline
Variable N Women Men
N (%) N (%)
Sex (n) 1034 544 (52.6) 490 (47.4)
Smoking 1018
Never 239 (44.6) 252 (52.2)
Former 163 (30.4) 124 (25.7)
Current 134 (25.0) 106 (21.9)
Marital status 1031
Never married 127 (23.5) 101 (20.7)
Married 327 (60.3) 321 (65.6)
Separated/divorced/widowed 88 (16.2) 67 (13.7)
Education (years) 1025
≥9 83 (15.4) 54 (11.1)
10–12 273 (50.7) 265 (54.4)
>12 182 (33.8) 168 (34.5)
Mean (SD) Mean (SD)
Age (years) 1034 50.4 (14.1) 50.2 (13.4)
Body mass index (kg/m2) 1031 26.4 (4.0) 26.4 (3.8)
Physical activity index 906 0.7 (0.8) 0.7 (0.8)
Systolic blood pressure (mm Hg) 1024 127.3 (17.1) 135.0 (14.0)
Diastolic blood pressure (mm Hg) 1024 71.3 (11.6) 78.1 (11.2)
Resting heart rate (bpm) 1026 70.7 (11.2) 66.2 (11.1)
Total serum cholesterol (mmol/L) 1028 5.6 (1.0) 5.6 (1.0)
HADS-Depression (0–21) 1034 2.9 (2.8) 2.6 (2.5)
HADS-Anxiety (0–21) 1034 3.7 (3.0) 3.5 (2.8)
Ejection fraction (EF) 1011 64.7 (10.1) 65.1 (9.6)
Mitral annular plane systolic excursion (MAPSE) (cm) 1034 1.6 (0.3) 1.6 (0.2)
Longitudinal global strain (%) 1034 −17.4 (2.3) −15.9 (2.2)
Longitudinal global strain rate (/s) 1018 −1.0 (-0.1) −1.0 (−0.1)
Systolic annular velocity (s0) (cm/s) 1023 8.2 (1.2) 8.6 (1.4)
Diastolic annular velocity (e0) (cm/s) 1023 11.9 (3.2) 10.7 (3.1)
Left ventricular mass index (g) 1015 162.0 (51.5) 162.7 (49.5)
Left atrial volume index (g) 200 3.6 (0.1) 3.6 (0.1)
HADS, Hospital Anxiety and Depression Scale.
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global strain in women. However, current symptoms of
depression or anxiety had no consistent associations
with subclinical LV dysfunction. As the study population
only consisted of healthy individuals, the effect of previ-
ous and repeated depression symptoms is unlikely to be
caused by reverse causality or existing disease. Further
research is needed before definitive conclusions are
drawn.
Comparisons with previous studies
To the best of our knowledge, only one previous echo-
cardiographic study11 has assessed the association of
current depression symptoms with novel echocardio-
graphic parameters. No study has assessed the impact of
anxiety symptoms or repeated measures of anxiety and
depression symptoms. Kim et al11 found that, in an older
population with complex medical comorbidity (hyper-
tension, diabetes mellitus and metabolic syndrome), the
prevalence of moderate to severe depression symptoms
was about 5%. Those who had moderate to severe
depression had a 4% reduction (95% CI 2% to 7%
reduction) in LV diastolic function measured by e0 com-
pared to those with no depression symptoms.11 Our
findings on previous and repeated depression symptoms
and cardiac function are in line with Kim et al11; both
studies find LV systolic function indices to be less
affected than diastolic indices. The indices of LV dia-
stolic and systolic function used in this study, e0 and lon-
gitudinal global strain, were chosen a priori, based on
previous knowledge of the high sensitivity for these mea-
sures to detect subclinical cardiac dysfunction12 that are
clinically relevant for prediction of future CVD.1
Longitudinal strain and e0 are linked to various CVD risk
factors and manifest CVD even though other indices of
LV systolic and diastolic function have been less influ-
enced.1 12 26–28
The differential associations for previous, repeated
versus current depression symptoms with cardiac dys-
function, might have several explanations. First, our
population had a lower prevalence of baseline depres-
sion symptoms than that in the study by Kim et al,11 thus
the different results could reflect a dose–response issue.
Second, previous research suggests that the relationship
between depression and anxiety symptoms with CVD
morbidity follows dose–response manners, not only in
terms of symptom level on one occasion,4 7 but also with
symptom duration.4 16 17 29 30 Both previous and
repeated depression symptoms include possibilities for
longer symptom duration than current depression symp-
toms. Longer symptom duration is associated with a
chronic stress response, including increased proinflam-
matory cytokines and neurohormonal stress activity,
which both negatively affect development towards CVD
disease.9 31 Third, as repeated depression symptoms are
associated with the most negative effect, it could be
hypothesised that a high score on one anxiety and
depression report could reflect a normal reaction to
stressful events, while high levels on both HUNT waves
may better capture cardiac risk related to depression
symptoms.4
In this study, women, but not men, were prone to have
subclinical LV systolic dysfunction associated with
repeated depression symptoms. One could speculate
whether this difference is due to altered
Figure 2 Association of early diastolic velocity (%) with
higher averaged score of two repeated HADS-D reports.
Table 2 Linear regression analysis for the % difference in early diastolic velocity (e0) per 5 unit rise in HADS-scores
Model 1 Model 3
N
Β=% difference per 5 HADS
units (95% CI) N
Β=% difference per 5 HADS
units (95% CI)
HADS-D 996 −2.5 (−6.1 to 0.1) 844 −1.9 (−7.5 to 3.6)
HADS-DP 675 −7.4 (−8.8 to −0.8) 566 −4.8 (−8.8 to −0.8)
HADS-DR 675 −10.3 (−15.8 to −4.9) 566 −8.3 (−13.9 to −2.7)
HADS-A 995 −1.6 (−4.7 to 1.6) 844 −1.9 (−5.1 to 1.28)
HADS-AP 652 −0.2 (−3.9 to 3.4) 564 −2.0 (−3.9 to 3.4)
HADS-AR 652 −1.7 (−6.8 to 2.5) 547 −1.4 (−6.5 to 3.8)
Model 1: Age, sex, resting heart rate. Model 2: Model 1 + Marital status and education (data not shown). Model 3: Model 2 + systolic blood
pressure, body mass index, smoking, physical activity index.
HADS-D, HADS-depression report from HUNT3; HADS-DP, Previous HADS-D report from HUNT2; HADS-DR, Repeated HADS-D reports
(average sum score of two reports of HADS-D from HUNT2 + HUNT3); HADS-A, HADS-anxiety reports from HUNT3; HADS-AP, Previous
HADS-A report from HUNT2; HADS-AR, Repeated HADS-A reports (average sum score of two reports of HADS-A from HUNT2 + HUNT3).
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pathophysiological responses to depression symptoms in
women.32 If so, this could be part of the pathway that
eventually leads to clinical CVD despite ‘clean’ coronary
arteries in women.33 However, as longitudinal strain is a
measure that at least partly is adjusted for cardiac size
(as strain is shortening per myocardial wall length), this
may interfere with observed sex difference.
We found neither previous, current nor repeated
anxiety symptoms to be associated with subclinical LV
dysfunction. One explanation might be differences in
behaviour and biological response, where individuals
with anxiety symptoms often seek and cohere with
medical and lifestyle advice, while individuals with
depression tend to have an unhealthy lifestyle associated
with both lower help-seeking and proinflammatory cyto-
kine release,34 35 which can adversely affect pathways in
the development towards CVD.9 31
Strengths and limitations
This study has apparent strengths, such as a random
inclusion of persons free from CVD, diabetes and hyper-
tension, which makes confounding due to complex
medical disease less likely than in Kim et al’s11 study.
Depressive and anxiety symptoms are known to be asso-
ciated with physical illness.36 37 The causal relationship
between mental health and physical illness has been pro-
posed to be bidirectional: anxiety and depression may
lead to, for example, high-blood pressure due to activa-
tion of the stress axis38–40; and at the same time, physical
illness is associated with inflammatory cytokine release,
which is especially shown to induce depression symp-
toms.9 41 In addition, the extensive adjustment for
potential confounders makes residual confounding due
to medical comorbidity less likely. All echocardiograms
and analyses were performed by one physician highly
experienced in echocardiography and deformation
imaging, blinded to information of symptoms of depres-
sion and anxiety, as well as to blood pressure and other
possible confounding factors.
The study also has some important limitations. The
cross-sectional nature of the study does not allow the dir-
ection of the association between repeated depression
symptoms and lowered diastolic function to be deter-
mined. Further, the participants were healthy both with
respect to anxiety and depression symptoms, and the
results may not necessarily be generalisable to other
populations.42 We had no reliable information on the
participants’ use of antidepressants. However, the most
common pharmacological treatments (selective sero-
tonin reuptake inhibitors, tricyclic antidepressants,
SNRIs) have shown to be relatively safe and effective in
cardiac patients.43 Thus, we have no reason to believe
that potential antidepressive use is causing the observed
effects between repeated depression symptoms and e0 in
these healthy participants.
Non-participants in HUNT3 had more severe depres-
sion and anxiety symptoms than did participants.44 As
only 68% had repeated reports of depression and
anxiety, one could speculate whether those with severe
symptoms were less likely to be able to participate at both
waves. Thus, the observed association between repeated
depression symptoms and e0 could be an underestima-
tion of the true effect. Future studies should include
samples with higher levels of anxiety and depression in
order to better evaluate the influence on LV function.
Perspectives
A previous study from the HUNT3 echocardiography
study allows us to compare the difference in LV function
associated with depression symptoms to traditional risk
factors for CVD.14 A 5-unit higher average score for two
HADS-Depression reports gives similar negative influ-
ence of LV diastolic function by e0 as 32 mm Hg higher
blood pressure for women and 25 mm Hg in men; or
6.8 years and 6.6 years higher age for women and men,
respectively.12 Compared to the associations of the well-
known CVD risk factors on LV diastolic function, the
effect size of repeated high levels of depression
Table 3 Linear regression analysis for the % difference in longitudinal global strain per 5 unit rise in HADS-scores
Women Men
Model 1 (n=459) Model 3 (n=459) Model 1 (n=459) Model 3 (n=459)
N
Β=% difference
per 5 HADS units
(95% CI) N
Β=% difference
per 5 HADS
units (95% CI) N
Β=% difference
per 5 HADS
units (95% CI) N
Β=% difference
per 5 HADS
units (95% CI)
HADS-D 526 −1.1 (−3.3 to 1.1) 445 −0.6 (−2.8 to 1.7) 482 3.4 (−0.8 to 6.0) 408 3.3 (−0.4 to 6.1)
HADS-DP 346 −3.0 (−5.9 to −0.1) 289 −1.9 (−4.8 to 1.5) 336 −2.7 (−5.4 to 0.1) 281 −1.9 (−4.8 to 1.1)
HADS-DR 346 −4.3 (−8.3 to −0.3) 289 −4.3 (−7.2 to 1.4) 336 −0.5 (−4.5 to 3.5) 281 0.1 (−4.2 to 4.3)
HADS-A 526 −0.8 (−2.8 to 1.2) 445 −0.8 (−2.9 to 1.3) 482 1.1 (−1.2 to 3.4) 408 0.6 (−1.9 to 3.2)
HADS-AP 329 −1.2 (−3.8 to 1.4) 274 −1.7 (−4.4 to 1.0) 329 −0.2 (−3.9 to 1.7) 274 −1.2 (4.2 to 1.7)
HADS-AR 329 −2.1 (−9.1 to 1.6) 274 −2.7 (−6.6 to 1.3) 329 −1.3 (−5.1 to 2.5) 274 −1.0 (−5.2 to 2.8)
Adjustments: Model 1: Age, heart rate during echocardiography. Model 2: Model 1 + marital status and education (data not shown). Model 3:
Models 1 + 2 + Systolic blood pressure, body mass index, smoking and physical activity index.
HADS-D: HADS-depression report from HUNT3. HADS-DP: Previous HADS-D report from HUNT2. HADS-DR: Repeated HADS-D reports
(average sum score of two reports of HADS-D from HUNT2 + HUNT3). HADS-A: HADS-anxiety reports from HUNT3. HADS-AP: Previous
HADS-A report from HUNT2. HADS-AR: Repeated HADS-A reports (average sum score of two reports of HADS-A from HUNT2 + HUNT3).
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symptoms is not negligible. Thus, it is interesting that
both the SADHART and CREATE trial found that
persons with previous history of depression symptoms
were especially responsive to medical treatment,45 46 and
it is plausible that repeated high levels of depression
symptoms represent a modifiable risk factor for CVD. In
clinical practice, anxiety and depression co-exist, and it
is advised to consider both conditions when planning
treatment strategies.10
CONCLUSION
Overall, this study found few positive associations
between symptoms of anxiety and depression with LV
subclinical dysfunction among healthy participants.
However, previous and repeated depression symptoms
were associated with subclinical LV diastolic dysfunction
(e0), and marginally in women with subclinical systolic
dysfunction (longitudinal global strain). As previous sub-
clinical diastolic dysfunction is shown to be an inde-
pendent predictor for future CVD, future research
should monitor levels of depression symptoms over time
in order to further establish the role of such modifiable
symptoms in the development of cardiac disease.
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